These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6175058)

  • 21. Regulation of immune responses aginst the syngeneic ADJ-PC-5 plasmacytoma in BALB-c mice. III. Induction of specific T suppressor cells to the BALB/c plasmacytoma ADJ-PC-5 during early stages of tumorigenesis.
    Haubeck HD; Kölsch E
    Immunology; 1982 Nov; 47(3):503-10. PubMed ID: 6215340
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Restoration of cyclophosphamide-induced suppression of thymus-derived cytotoxic cell generation by normal thymocytes.
    Merluzzi VJ; Faanes RB; Choi YS
    Cancer Res; 1979 Sep; 39(9):3647-54. PubMed ID: 157806
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immune responses to weakly immunogenic murine-leukemia-virus-induced tumors. VIII. Characterization of suppressor cells.
    Deutsch O; Devens B; Naor D
    Isr J Med Sci; 1980 Jul; 16(7):538-44. PubMed ID: 6447123
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of self carriers in the immune response and tolerance. VI. Induction and reversal of TNP-modified self unresponsiveness in vitro.
    Li JT; Scott DW
    J Immunol; 1980 Dec; 125(6):2380-4. PubMed ID: 6968782
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of immune response in allogeneic mixed spleen cell cultures. I. Influence of I-region on the generation of suppressor cells.
    Kim YT; Schwartz A; Moody C; Siskind GW; Weksler ME
    J Immunol; 1980 Oct; 125(4):1724-9. PubMed ID: 6447730
    [TBL] [Abstract][Full Text] [Related]  

  • 26. B cell-deprived mice lack functional expression of certain T suppressor cell subsets.
    Flood PM; Janeway CA; Gershon RK
    J Mol Cell Immunol; 1984; 1(3):167-76. PubMed ID: 6242856
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Suppression of the mixed leukocyte response and of graft-vs-host disease by spleen cells following total lymphoid irradiation (TLI).
    King DP; Srober S; Kaplan HS
    J Immunol; 1981 Mar; 126(3):1140-5. PubMed ID: 6450802
    [TBL] [Abstract][Full Text] [Related]  

  • 28. T cells from naive mice suppress the in vitro cytotoxic response against endogenous Gross virus-induced tumor cells.
    Tilkin AF; Gomard E; Begue B; Levy JP
    J Immunol; 1984 Jan; 132(1):520-6. PubMed ID: 6228582
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cloned natural suppressor cells derived from the neonatal spleen: in vitro action and lineage.
    Schwadron RB; Strober S
    Transplant Proc; 1987 Feb; 19(1 Pt 1):533-5. PubMed ID: 2978921
    [No Abstract]   [Full Text] [Related]  

  • 30. The immunologic function of 1B2+ double negative (CD4-CD8-) T cells in the 2C transgenic mouse.
    Margenthaler JA; Flye MW
    J Surg Res; 2005 Jun; 126(2):160-6. PubMed ID: 15919414
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulatory mechanisms in cytotoxic T lymphocyte development. I. A suppressor T cell subset that regulates the proliferative stage of CTL development.
    Susskind BM; Merluzzi VJ; Faanes RB; Palladino MA; Choi YS
    J Immunol; 1983 Feb; 130(2):527-32. PubMed ID: 6217242
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enterically induced regulation of systemic immune responses. II. Suppression of proliferating T cells by an Lyt-1+, 2- T effector cell.
    Silverman GA; Peri BA; Fitch FW; Rothberg RM
    J Immunol; 1983 Dec; 131(6):2656-61. PubMed ID: 6196395
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of the activation of cytotoxic T lymphocytes by prostaglandins and antigens.
    Ting CC; Hargrove ME
    J Immunol; 1984 Aug; 133(2):660-6. PubMed ID: 6203973
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Requirement of CD4+ T cells and antigen-presenting cells for primary in vitro generation of CD8+ cytotoxic T cells against Ld-binding self-peptide p2Ca.
    Wada H; Ono T; Uenaka A; Monden M; Nakayama E
    Immunology; 1995 Apr; 84(4):633-7. PubMed ID: 7790038
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor cell-triggered macrophage-mediated suppression of the T-cell cytotoxic response to tumor-associated antigens. I. Characterization of the cell components for induction of suppression.
    Ting CC; Rodrigues D
    J Natl Cancer Inst; 1982 Oct; 69(4):867-72. PubMed ID: 6214653
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Absorption of normal lymphocytes on allogeneic spleen monolayers: depletion of alloreactivity is due to inhibition of CTL induction by released monolayer cells.
    Kelso A
    J Immunol; 1981 Oct; 127(4):1563-9. PubMed ID: 6456308
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence for interaction between T cell populations of tumor-bearing and normal mice in immune suppression.
    Ingenito GG; Calkins CE
    J Immunol; 1981 Sep; 127(3):1236-40. PubMed ID: 6455472
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Murine T cell suppression demonstrable in the absence of cytotoxicity and the effect of Cyclosporin A on this system.
    Hutchings PR; Cooke A; Gunn HC
    J Immunol; 1983 Mar; 130(3):1071-6. PubMed ID: 6218198
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-CD2 mAbs suppress cytotoxic lymphocyte activity by the generation of Th2 suppressor cells and receptor blockade.
    Chavin KD; Qin L; Yon R; Lin J; Yagita H; Bromberg JS
    J Immunol; 1994 Apr; 152(8):3729-39. PubMed ID: 7908306
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Norepinephrine-mediated inhibition of antitumor cytotoxic T lymphocyte generation involves a beta-adrenergic receptor mechanism and decreased TNF-alpha gene expression.
    Kalinichenko VV; Mokyr MB; Graf LH; Cohen RL; Chambers DA
    J Immunol; 1999 Sep; 163(5):2492-9. PubMed ID: 10452985
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.